SureTrader
Cannabis Stocks News
Interactive Brokers Advertisement
Home > Boards > US Listed > Biotechs > Amarin Corp. PLC ADS (AMRN)

Holy shit! Wow, FDA hires Grail Sipes, former

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (3) | Next 10 | Previous | Next
Biobillionair Member Profile
 
Followed By 67
Posts 10,274
Boards Moderated 1
Alias Born 01/12/13
160x600 placeholder
Amarin to Present at Cantor Global Healthcare Conference "GlobeNewswire Inc." - 9/20/2017 4:30:00 PM
Amarin Appoints Mark W. Salyer to New Position of Chief Commercial Officer "GlobeNewswire Inc." - 9/13/2017 6:00:00 AM
Amarin to Present at Rodman & Renshaw’s Global Investment Conference "GlobeNewswire Inc." - 9/6/2017 6:00:00 AM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 8/30/2017 4:02:36 PM
Amarin's REDUCE-IT Cardiovascular Outcomes Study of Vascepa to Continue as Planned at Recommendation of Independent Data Moni... "GlobeNewswire Inc." - 8/14/2017 6:00:00 AM
Securities Registration: Employee Benefit Plan (s-8) "Edgar (US Regulatory)" - 8/2/2017 5:06:42 PM
Quarterly Report (10-q) "Edgar (US Regulatory)" - 8/2/2017 6:38:43 AM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 8/2/2017 6:31:46 AM
Amarin Reports Second Quarter 2017 Financial Results and Provides Update on Operations "GlobeNewswire Inc." - 8/2/2017 5:30:00 AM
Amarin to Report Second Quarter 2017 Results and Host Conference Call on August 2, 2017 "GlobeNewswire Inc." - 7/26/2017 4:30:00 PM
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 7/3/2017 7:22:58 PM
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 7/3/2017 7:22:30 PM
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 7/3/2017 7:22:02 PM
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 7/3/2017 7:20:53 PM
Amarin Corporation plc (Nasdaq: AMRN) to Ring The Nasdaq Stock Market Opening Bell "GlobeNewswire Inc." - 6/12/2017 10:00:00 AM
Vascepa® (Icosapent Ethyl) Showed Reductions in Potentially Atherogenic Lipid Parameters in Statin-Treated Women With Type 2... "GlobeNewswire Inc." - 6/12/2017 7:00:00 AM
Amarin to Present at the Jefferies 2017 Global Healthcare Conference "GlobeNewswire Inc." - 6/1/2017 6:00:00 AM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 5/19/2017 9:07:06 AM
Amarin Announces Expanded Research Relationships and Studies to Help Improve Cardiovascular Care "GlobeNewswire Inc." - 5/18/2017 6:00:00 AM
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 5/17/2017 5:26:59 PM
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 5/17/2017 5:26:08 PM
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 5/17/2017 5:25:42 PM
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 5/17/2017 5:24:50 PM
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 5/17/2017 5:23:06 PM
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 5/17/2017 5:14:55 PM
Biobillionair   Friday, 10/31/14 10:55:20 PM
Re: None
Post # of 114619 
Holy shit! Wow, FDA hires Grail Sipes, former partner at Covington's, as CDER policy director. Definitely a sign!
New CDER Compliance Director is from DOJ

Office of Regulatory Policy
Director
Grail Sipes, J.D.
(DKKNAA)

Grail wife of Christopher Sipes, attorney who represent Amarin at June OB meeting and NCE suit !!!


Kurt R. Karst, Robert Dormer, Josephine Torrente (Hyman, Phelps & McNamara); Joseph Kennedy, Steven Ketchum, Peggy Berry, Paresh Soni, Barbara Kurys (Amarin); Christopher Sipes (Covington & Burling)


http://www.fda.gov/AboutFDA/CentersOffices/OrganizationCharts/ucm184745.htm

Office of Compliance
Director
Cynthia Schnedar


Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (3) | Next 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist